Reduced-dose Radiation Therapy to the Primary Site is Effective for High-risk Neuroblastoma: Results from a Prospective Trial

PURPOSE: For patients with high-risk neuroblastoma (HR-NB), a dose of 21 Gy to the primary tumor site after gross total resection (GTR) provides excellent local control. However, no clinical trial has specifically evaluated the optimal dose of radiation therapy (RT), and RT-related long-term toxicit...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Radiat Oncol Biol Phys
Autors principals: Casey, Dana L., Kushner, Brian H., Cheung, Nai-Kong V., Modak, Shakeel, Basu, Ellen M., Roberts, Stephen S., LaQuaglia, Michael P., Wolden, Suzanne L.
Format: Artigo
Idioma:Inglês
Publicat: 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6499671/
https://ncbi.nlm.nih.gov/pubmed/30763661
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2019.02.004
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars